Maricela C. Valerio - Infectious Diseases

Author Information

Dr. Maricela C. Valerio is a distinguished researcher in the field of Infectious Diseases, affiliated with the Servicio de Microbiología Clínica y Enfermedades Infecciosas at the Hospital General Universitario Gregorio Marañón in Madrid, Spain. She is also associated with the Instituto de Investigación Sanitaria Gregorio Marañón, located in Madrid. Dr. Valerio's work primarily focuses on infectious diseases, with a significant emphasis on conditions associated with COVID-19, fungal infections, and post-transplant complications.

Research Contributions

Dr. Valerio has made substantial contributions to the understanding and management of infectious diseases. Her research includes significant findings on the post-COVID-19 syndrome, highlighting the presence of SARS-CoV-2 RNA in various bodily fluids of patients with persistent symptoms. She has also evaluated the performance of point-of-care antigen detection devices for SARS-CoV-2 and investigated the incidence of candidemia in COVID-19 patients. Her work has explored complex cases such as infective endocarditis in younger populations and the challenges of diagnosing invasive aspergillosis in solid organ transplant recipients. Additionally, she has researched the treatment of Clostridioides difficile infections and the management of carbapenem-resistant Enterobacteriaceae infections post-liver transplantation.

Aliases

Dr. Valerio is known by several aliases, including Maricela Valerio, Maricela C Valerio, M Valerio, M. Valerio, and Maricela C. Valerio. These variations may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Papers	185
Total Citations	4229
H-Index	38

Publications:

Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19

DOI: 10.1186/s12879-022-07153-4

Year: 2022

Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

DOI: 10.1016/j.cmi.2022.02.014

Year: 2022

Incidence of Candidemia Is Higher in COVID-19 versus Non-COVID-19 Patients, but Not Driven by Intrahospital Transmission

DOI: 10.3390/jof8030305

Year: 2022

Infective endocarditis in children and adolescents: a different profile with clinical implications

DOI: 10.1038/s41390-022-01959-3

Year: 2022

Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience.

DOI: 10.37201/req/120.2021

Year: 2022

Late Cytomegalovirus Primoinfection in a Heart Transplant Recipient After COVID-19 Vaccine

DOI: 10.1016/j.healun.2022.01.1696

Year: 2022

Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)

DOI: 10.1111/myc.13298

Year: 2021

Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain

DOI: 10.1080/17512433.2021.1875819

Year: 2021

Development of a Risk Prediction Model for Carbapenem-Resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study.

DOI: 10.1093/cid/ciab109

Year: 2021

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges

DOI: 10.1007/s00134-021-06510-2

Year: 2021

What Role Does Testing Play in Monogamous Relationships?

Why are Throat Swabs Important in Infectious Diseases?

How Are Infectious Diseases Diagnosed?

What are the complications?

How Do Serological Tests Work?

What Challenges Does the RBM Partnership Face?

What Treatments are Available for Bacterial Infections?

How Are Drug Targets Identified?

Why Are Cohort Studies Important?

What Challenges Does the Global Fund Face?

Partnered Content Networks

Relevant Topics